The biopharmaceuticals SPAC was co-founded by CEO Dr. Clive Meanwellis. CFO Chris Visioli, who previously worked for The Medicines Company, in that role raised over $300 million in outside capital and co-managed the global business development process which resulted in the sale of the company to Novartis AG for $9.7 billion in January. Read more.
Population Health Amends $150M IPO
